

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sensory perception of smell (GO:0007608) | 5.49661003 |
| 2 | neurofilament cytoskeleton organization (GO:0060052) | 5.20390083 |
| 3 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.80348540 |
| 4 | negative regulation of dendrite morphogenesis (GO:0050774) | 4.67103680 |
| 5 | neuron cell-cell adhesion (GO:0007158) | 4.50647795 |
| 6 | negative regulation of microtubule polymerization (GO:0031115) | 4.48647363 |
| 7 | cell migration in hindbrain (GO:0021535) | 4.35168883 |
| 8 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 4.33022805 |
| 9 | detection of temperature stimulus (GO:0016048) | 4.28923892 |
| 10 | sensory perception of chemical stimulus (GO:0007606) | 4.27005532 |
| 11 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 4.20040549 |
| 12 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 4.20040549 |
| 13 | * neuronal action potential (GO:0019228) | 4.12045881 |
| 14 | phenol-containing compound catabolic process (GO:0019336) | 4.03509987 |
| 15 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.91645011 |
| 16 | sympathetic nervous system development (GO:0048485) | 3.90307664 |
| 17 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.86875591 |
| 18 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.83721842 |
| 19 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.80319141 |
| 20 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 3.79820176 |
| 21 | nucleobase catabolic process (GO:0046113) | 3.79667236 |
| 22 | protein localization to cilium (GO:0061512) | 3.74918617 |
| 23 | detection of calcium ion (GO:0005513) | 3.74033768 |
| 24 | protein carboxylation (GO:0018214) | 3.73341813 |
| 25 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.73341813 |
| 26 | peripheral nervous system neuron development (GO:0048935) | 3.69395918 |
| 27 | proline transport (GO:0015824) | 3.64081964 |
| 28 | negative regulation of axon guidance (GO:1902668) | 3.63896514 |
| 29 | mating behavior (GO:0007617) | 3.57666499 |
| 30 | behavioral response to nicotine (GO:0035095) | 3.57619830 |
| 31 | negative regulation of fibrinolysis (GO:0051918) | 3.53557761 |
| 32 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.45070457 |
| 33 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.44911712 |
| 34 | * membrane depolarization during action potential (GO:0086010) | 3.43452878 |
| 35 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.42374408 |
| 36 | neuromuscular synaptic transmission (GO:0007274) | 3.40471969 |
| 37 | protein polyglutamylation (GO:0018095) | 3.39033672 |
| 38 | regulation of fibrinolysis (GO:0051917) | 3.36662750 |
| 39 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.36449293 |
| 40 | synaptic vesicle exocytosis (GO:0016079) | 3.35018539 |
| 41 | neuronal action potential propagation (GO:0019227) | 3.32262923 |
| 42 | * response to pain (GO:0048265) | 3.26678075 |
| 43 | behavioral response to ethanol (GO:0048149) | 3.25645978 |
| 44 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.23126683 |
| 45 | negative regulation of dendrite development (GO:2000171) | 3.22515533 |
| 46 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.20758506 |
| 47 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.17953385 |
| 48 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 3.17456325 |
| 49 | glutamate secretion (GO:0014047) | 3.16712679 |
| 50 | regulation of axon guidance (GO:1902667) | 3.16008479 |
| 51 | cellular response to nicotine (GO:0071316) | 3.13185932 |
| 52 | retinal ganglion cell axon guidance (GO:0031290) | 3.11527881 |
| 53 | synaptic vesicle maturation (GO:0016188) | 3.11469330 |
| 54 | sensory perception of taste (GO:0050909) | 3.05768113 |
| 55 | establishment of mitochondrion localization (GO:0051654) | 3.05304517 |
| 56 | mitochondrion transport along microtubule (GO:0047497) | 3.04521973 |
| 57 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.04521973 |
| 58 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.04201595 |
| 59 | regulation of protein kinase A signaling (GO:0010738) | 3.02408323 |
| 60 | innervation (GO:0060384) | 3.01893479 |
| 61 | gamma-aminobutyric acid transport (GO:0015812) | 3.01552096 |
| 62 | axon extension involved in axon guidance (GO:0048846) | 3.01278431 |
| 63 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 3.01278431 |
| 64 | axonal fasciculation (GO:0007413) | 3.00092661 |
| 65 | urinary tract smooth muscle contraction (GO:0014848) | 2.99947377 |
| 66 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.99933681 |
| 67 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.99462288 |
| 68 | sequestering of actin monomers (GO:0042989) | 2.98235068 |
| 69 | peptidyl-glutamic acid modification (GO:0018200) | 2.97654381 |
| 70 | endocardial cushion development (GO:0003197) | 2.97487609 |
| 71 | regulation of synaptic vesicle transport (GO:1902803) | 2.96185001 |
| 72 | calcium ion-dependent exocytosis (GO:0017156) | 2.94924905 |
| 73 | renal tubule morphogenesis (GO:0061333) | 2.94409446 |
| 74 | intestinal cholesterol absorption (GO:0030299) | 2.93563688 |
| 75 | activation of protein kinase A activity (GO:0034199) | 2.93407392 |
| 76 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 2.92600811 |
| 77 | ER overload response (GO:0006983) | 2.91523528 |
| 78 | response to water (GO:0009415) | 2.89920614 |
| 79 | nephron tubule morphogenesis (GO:0072078) | 2.89325876 |
| 80 | nephron epithelium morphogenesis (GO:0072088) | 2.89325876 |
| 81 | cellular response to glucagon stimulus (GO:0071377) | 2.88228972 |
| 82 | * action potential (GO:0001508) | 2.87550788 |
| 83 | axon extension (GO:0048675) | 2.87516852 |
| 84 | negative regulation of cation channel activity (GO:2001258) | 2.87383870 |
| 85 | positive regulation of male gonad development (GO:2000020) | 2.85969803 |
| 86 | catecholamine biosynthetic process (GO:0042423) | 2.85577449 |
| 87 | catechol-containing compound biosynthetic process (GO:0009713) | 2.85577449 |
| 88 | axoneme assembly (GO:0035082) | 2.85072352 |
| 89 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.84525095 |
| 90 | cellular response to prostaglandin stimulus (GO:0071379) | 2.83933627 |
| 91 | maternal behavior (GO:0042711) | 2.83419221 |
| 92 | tachykinin receptor signaling pathway (GO:0007217) | 2.83291498 |
| 93 | organelle transport along microtubule (GO:0072384) | 2.82932881 |
| 94 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.82455545 |
| 95 | neuron fate specification (GO:0048665) | 2.82203228 |
| 96 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.81759294 |
| 97 | positive regulation of action potential (GO:0045760) | 2.81509285 |
| 98 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.79790581 |
| 99 | neuron recognition (GO:0008038) | 2.79061527 |
| 100 | regulation of plasminogen activation (GO:0010755) | 2.79013447 |
| 101 | protein localization to synapse (GO:0035418) | 2.78843048 |
| 102 | neurotransmitter secretion (GO:0007269) | 2.78732901 |
| 103 | chondrocyte proliferation (GO:0035988) | 2.76944480 |
| 104 | cell communication involved in cardiac conduction (GO:0086065) | 2.76628321 |
| 105 | positive regulation of synapse assembly (GO:0051965) | 2.76588721 |
| 106 | regulation of cell communication by electrical coupling (GO:0010649) | 2.75684532 |
| 107 | cilium morphogenesis (GO:0060271) | 2.74709795 |
| 108 | dopamine receptor signaling pathway (GO:0007212) | 2.74653187 |
| 109 | synapse assembly (GO:0007416) | 2.73963796 |
| 110 | neuromuscular process controlling posture (GO:0050884) | 2.73856597 |
| 111 | axon cargo transport (GO:0008088) | 2.72285660 |
| 112 | dopamine biosynthetic process (GO:0042416) | 2.72239066 |
| 113 | catecholamine transport (GO:0051937) | 2.71060667 |
| 114 | kidney mesenchyme development (GO:0072074) | 2.71044684 |
| 115 | positive regulation of amino acid transport (GO:0051957) | 2.70580320 |
| 116 | microtubule-based transport (GO:0010970) | 2.70251651 |
| 117 | detection of mechanical stimulus involved in sensory perception (GO:0050974) | 2.69116543 |
| 118 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.67358088 |
| 119 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.66930139 |
| 120 | negative chemotaxis (GO:0050919) | 2.66906872 |
| 121 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.66862671 |
| 122 | regulation of neurotransmitter secretion (GO:0046928) | 2.64688499 |
| 123 | positive regulation of potassium ion transport (GO:0043268) | 2.64559368 |
| 124 | brain morphogenesis (GO:0048854) | 2.63542330 |
| 125 | inositol phosphate catabolic process (GO:0071545) | 2.62877514 |
| 126 | vesicle transport along microtubule (GO:0047496) | 2.62849285 |
| 127 | hindbrain development (GO:0030902) | 2.62609634 |
| 128 | regulation of male gonad development (GO:2000018) | 2.62335763 |
| 129 | regulation of vesicle fusion (GO:0031338) | 2.61527658 |
| 130 | melanosome transport (GO:0032402) | 2.61049461 |
| 131 | multi-organism reproductive behavior (GO:0044705) | 2.60067489 |
| 132 | neurotransmitter catabolic process (GO:0042135) | 2.58689074 |
| 133 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.58006555 |
| 134 | collagen fibril organization (GO:0030199) | 2.57565832 |
| 135 | response to pheromone (GO:0019236) | 2.57191101 |
| 136 | cytoskeleton-dependent intracellular transport (GO:0030705) | 2.56236702 |
| 137 | indolalkylamine metabolic process (GO:0006586) | 2.55972877 |
| 138 | neurotransmitter transport (GO:0006836) | 2.55632406 |
| 139 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.55162799 |
| 140 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 2.53460788 |
| 141 | regulation of action potential (GO:0098900) | 2.49920145 |
| 142 | regulation of dopamine secretion (GO:0014059) | 2.48091370 |
| 143 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.47753057 |
| 144 | negative regulation of mast cell activation (GO:0033004) | 2.47356490 |
| 145 | cell adhesion mediated by integrin (GO:0033627) | 2.45378871 |
| 146 | presynaptic membrane assembly (GO:0097105) | 2.43382347 |
| 147 | cranial nerve morphogenesis (GO:0021602) | 2.42226481 |
| 148 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.41788074 |
| 149 | inner ear receptor cell development (GO:0060119) | 2.38550689 |
| 150 | regulation of synapse assembly (GO:0051963) | 2.37533428 |
| 151 | postsynaptic membrane organization (GO:0001941) | 2.36889243 |
| 152 | smooth muscle contraction (GO:0006939) | 2.36390167 |
| 153 | ganglion development (GO:0061548) | 2.35904011 |
| 154 | peristalsis (GO:0030432) | 2.35604206 |
| 155 | negative regulation of axon extension (GO:0030517) | 2.35043779 |
| 156 | indolalkylamine catabolic process (GO:0046218) | 2.34967797 |
| 157 | tryptophan catabolic process (GO:0006569) | 2.34967797 |
| 158 | indole-containing compound catabolic process (GO:0042436) | 2.34967797 |
| 159 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.34883562 |
| 160 | tryptophan metabolic process (GO:0006568) | 2.34549452 |
| 161 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.34109197 |
| 162 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.32549336 |
| 163 | substrate-dependent cell migration (GO:0006929) | 2.31360358 |
| 164 | regulation of protein activation cascade (GO:2000257) | 2.30930030 |
| 165 | negative regulation of chemotaxis (GO:0050922) | 2.28010544 |
| 166 | dendrite morphogenesis (GO:0048813) | 2.26264236 |
| 167 | dopamine transport (GO:0015872) | 2.25290507 |
| 168 | epithelial cell differentiation involved in kidney development (GO:0035850) | 2.24781344 |
| 169 | negative regulation of protein activation cascade (GO:2000258) | 2.23766089 |
| 170 | metanephric mesenchyme development (GO:0072075) | 2.22960401 |
| 171 | lipid translocation (GO:0034204) | 2.22659479 |
| 172 | phospholipid translocation (GO:0045332) | 2.22659479 |
| 173 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.22248470 |
| 174 | positive regulation of axon extension (GO:0045773) | 2.22137199 |
| 175 | regulation of feeding behavior (GO:0060259) | 2.21082006 |
| 176 | regulation of axon extension (GO:0030516) | 2.20931657 |
| 177 | regulation of complement activation (GO:0030449) | 2.20889195 |
| 178 | auditory behavior (GO:0031223) | 2.20383012 |
| 179 | response to auditory stimulus (GO:0010996) | 2.20273920 |
| 180 | neuron projection extension (GO:1990138) | 2.20035621 |
| 181 | microtubule severing (GO:0051013) | 2.19627754 |
| 182 | cerebral cortex cell migration (GO:0021795) | 2.19237698 |
| 183 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.16666321 |
| 184 | ribonucleoprotein complex disassembly (GO:0032988) | 2.15634474 |
| 185 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 2.14500491 |
| 186 | negative regulation of activin receptor signaling pathway (GO:0032926) | 2.14251320 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.82803790 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.39447013 |
| 3 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.24812810 |
| 4 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.98930093 |
| 5 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.93122570 |
| 6 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.67351692 |
| 7 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.62288748 |
| 8 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.45710467 |
| 9 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.43082121 |
| 10 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.36747535 |
| 11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.35838061 |
| 12 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.26224025 |
| 13 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.26224025 |
| 14 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.19077214 |
| 15 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.18196133 |
| 16 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.15534635 |
| 17 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.12499045 |
| 18 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.12447834 |
| 19 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.07209550 |
| 20 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.04285380 |
| 21 | FUS_26573619_Chip-Seq_HEK293_Human | 2.04058471 |
| 22 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.03368735 |
| 23 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.02989244 |
| 24 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.00672903 |
| 25 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.97476367 |
| 26 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.96714991 |
| 27 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.94589925 |
| 28 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.86379602 |
| 29 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.85880905 |
| 30 | TP53_16413492_ChIP-PET_HCT116_Human | 1.85500751 |
| 31 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.84583295 |
| 32 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.82105320 |
| 33 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.80638828 |
| 34 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.77669673 |
| 35 | VDR_22108803_ChIP-Seq_LS180_Human | 1.77517690 |
| 36 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.77515045 |
| 37 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.76707599 |
| 38 | P300_19829295_ChIP-Seq_ESCs_Human | 1.75412857 |
| 39 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.73002655 |
| 40 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.69386699 |
| 41 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.68765228 |
| 42 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.66667502 |
| 43 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.66315995 |
| 44 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.63079585 |
| 45 | EWS_26573619_Chip-Seq_HEK293_Human | 1.61283799 |
| 46 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.57258754 |
| 47 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.57062354 |
| 48 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.57062354 |
| 49 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.54941685 |
| 50 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.52097179 |
| 51 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.47377668 |
| 52 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.46043400 |
| 53 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.45245791 |
| 54 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.45159075 |
| 55 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.44879331 |
| 56 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.41968571 |
| 57 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.41476637 |
| 58 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.40971397 |
| 59 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.36898107 |
| 60 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.36473230 |
| 61 | * CBP_20019798_ChIP-Seq_JUKART_Human | 1.33992444 |
| 62 | * IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.33992444 |
| 63 | STAT3_23295773_ChIP-Seq_U87_Human | 1.32102462 |
| 64 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.31949335 |
| 65 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.31421998 |
| 66 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.29197854 |
| 67 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.27225210 |
| 68 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.26366520 |
| 69 | AR_25329375_ChIP-Seq_VCAP_Human | 1.25168298 |
| 70 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.24393636 |
| 71 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.22383305 |
| 72 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.22104263 |
| 73 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.21819377 |
| 74 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.21635998 |
| 75 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.21223983 |
| 76 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.20832549 |
| 77 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.20434656 |
| 78 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.19975030 |
| 79 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.19784682 |
| 80 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.19514965 |
| 81 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.18100492 |
| 82 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.17359533 |
| 83 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.17291451 |
| 84 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.15574916 |
| 85 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.15146153 |
| 86 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.14905182 |
| 87 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.14772396 |
| 88 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.14271805 |
| 89 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.14258421 |
| 90 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.12671387 |
| 91 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.12301934 |
| 92 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.11714239 |
| 93 | * KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.11525531 |
| 94 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10912836 |
| 95 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.10199498 |
| 96 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.10181814 |
| 97 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.09820955 |
| 98 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.09792062 |
| 99 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.09648101 |
| 100 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.08154861 |
| 101 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08154861 |
| 102 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.07458244 |
| 103 | TCF4_23295773_ChIP-Seq_U87_Human | 1.07401084 |
| 104 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.06986759 |
| 105 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.06932314 |
| 106 | JUN_21703547_ChIP-Seq_K562_Human | 1.06861973 |
| 107 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.06315517 |
| 108 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.06201939 |
| 109 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.05889741 |
| 110 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.05814410 |
| 111 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.05669248 |
| 112 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.04967053 |
| 113 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.04026965 |
| 114 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.03460313 |
| 115 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.02399546 |
| 116 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.00410350 |
| 117 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.99682567 |
| 118 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.97098528 |
| 119 | KDM2B_26808549_Chip-Seq_REH_Human | 0.95320208 |
| 120 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.93861587 |
| 121 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92137147 |
| 122 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.91878639 |
| 123 | AR_19668381_ChIP-Seq_PC3_Human | 0.91548383 |
| 124 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.91530226 |
| 125 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.91428898 |
| 126 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.91425610 |
| 127 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.90310534 |
| 128 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.88264037 |
| 129 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.88229147 |
| 130 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.87912375 |
| 131 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.87484592 |
| 132 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.87484592 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002735_abnormal_chemical_nociception | 4.75192837 |
| 2 | MP0006276_abnormal_autonomic_nervous | 4.61662182 |
| 3 | MP0001984_abnormal_olfaction | 4.08131002 |
| 4 | MP0001968_abnormal_touch/_nociception | 4.03496020 |
| 5 | MP0004270_analgesia | 4.01974471 |
| 6 | MP0002734_abnormal_mechanical_nocicepti | 3.56514936 |
| 7 | MP0002736_abnormal_nociception_after | 3.44254407 |
| 8 | MP0008438_abnormal_cutaneous_collagen | 3.18622440 |
| 9 | MP0002733_abnormal_thermal_nociception | 3.12640593 |
| 10 | MP0004858_abnormal_nervous_system | 3.10962840 |
| 11 | MP0001986_abnormal_taste_sensitivity | 3.04923052 |
| 12 | MP0005645_abnormal_hypothalamus_physiol | 3.02318901 |
| 13 | MP0003195_calcinosis | 2.92062234 |
| 14 | MP0001970_abnormal_pain_threshold | 2.78732704 |
| 15 | MP0002822_catalepsy | 2.70853886 |
| 16 | MP0010386_abnormal_urinary_bladder | 2.58333187 |
| 17 | MP0002184_abnormal_innervation | 2.54882449 |
| 18 | MP0005503_abnormal_tendon_morphology | 2.22408818 |
| 19 | MP0002272_abnormal_nervous_system | 2.21416560 |
| 20 | MP0002751_abnormal_autonomic_nervous | 2.19763121 |
| 21 | MP0004272_abnormal_basement_membrane | 2.17255502 |
| 22 | MP0006054_spinal_hemorrhage | 2.17255483 |
| 23 | MP0005084_abnormal_gallbladder_morpholo | 2.10917448 |
| 24 | * MP0003635_abnormal_synaptic_transmissio | 2.10761886 |
| 25 | MP0005085_abnormal_gallbladder_physiolo | 2.08983934 |
| 26 | MP0008789_abnormal_olfactory_epithelium | 2.04276193 |
| 27 | MP0004859_abnormal_synaptic_plasticity | 2.02570382 |
| 28 | MP0003880_abnormal_central_pattern | 2.00600965 |
| 29 | MP0005360_urolithiasis | 2.00234110 |
| 30 | MP0000372_irregular_coat_pigmentation | 1.96263892 |
| 31 | MP0005499_abnormal_olfactory_system | 1.94715088 |
| 32 | MP0005394_taste/olfaction_phenotype | 1.94715088 |
| 33 | MP0002638_abnormal_pupillary_reflex | 1.94697437 |
| 34 | MP0002067_abnormal_sensory_capabilities | 1.89971270 |
| 35 | MP0009745_abnormal_behavioral_response | 1.86852882 |
| 36 | MP0010368_abnormal_lymphatic_system | 1.86235166 |
| 37 | MP0003950_abnormal_plasma_membrane | 1.83357490 |
| 38 | MP0003252_abnormal_bile_duct | 1.80884755 |
| 39 | MP0002572_abnormal_emotion/affect_behav | 1.80434259 |
| 40 | MP0002063_abnormal_learning/memory/cond | 1.78047312 |
| 41 | MP0005365_abnormal_bile_salt | 1.74779529 |
| 42 | MP0005423_abnormal_somatic_nervous | 1.74590401 |
| 43 | MP0002102_abnormal_ear_morphology | 1.68794159 |
| 44 | MP0001905_abnormal_dopamine_level | 1.66035122 |
| 45 | MP0009046_muscle_twitch | 1.65310543 |
| 46 | * MP0002064_seizures | 1.61162275 |
| 47 | MP0003122_maternal_imprinting | 1.60708771 |
| 48 | MP0000778_abnormal_nervous_system | 1.60682260 |
| 49 | MP0001440_abnormal_grooming_behavior | 1.60182230 |
| 50 | MP0002909_abnormal_adrenal_gland | 1.59622123 |
| 51 | MP0005646_abnormal_pituitary_gland | 1.57732608 |
| 52 | MP0009384_cardiac_valve_regurgitation | 1.55422445 |
| 53 | MP0001501_abnormal_sleep_pattern | 1.53816711 |
| 54 | MP0003183_abnormal_peptide_metabolism | 1.53388990 |
| 55 | MP0003868_abnormal_feces_composition | 1.52961710 |
| 56 | MP0000538_abnormal_urinary_bladder | 1.52076031 |
| 57 | MP0002139_abnormal_hepatobiliary_system | 1.51933370 |
| 58 | MP0002557_abnormal_social/conspecific_i | 1.50790193 |
| 59 | MP0001529_abnormal_vocalization | 1.43198129 |
| 60 | MP0000955_abnormal_spinal_cord | 1.42980846 |
| 61 | MP0004811_abnormal_neuron_physiology | 1.41791806 |
| 62 | MP0001188_hyperpigmentation | 1.41386931 |
| 63 | MP0002882_abnormal_neuron_morphology | 1.35356806 |
| 64 | MP0005386_behavior/neurological_phenoty | 1.29722726 |
| 65 | MP0004924_abnormal_behavior | 1.29722726 |
| 66 | MP0003942_abnormal_urinary_system | 1.27117934 |
| 67 | MP0002837_dystrophic_cardiac_calcinosis | 1.25347135 |
| 68 | MP0005379_endocrine/exocrine_gland_phen | 1.24552649 |
| 69 | MP0005187_abnormal_penis_morphology | 1.23709649 |
| 70 | MP0001486_abnormal_startle_reflex | 1.22481094 |
| 71 | MP0003787_abnormal_imprinting | 1.21536176 |
| 72 | MP0005623_abnormal_meninges_morphology | 1.18668755 |
| 73 | MP0002160_abnormal_reproductive_system | 1.18179047 |
| 74 | MP0005257_abnormal_intraocular_pressure | 1.15986981 |
| 75 | MP0002163_abnormal_gland_morphology | 1.15982409 |
| 76 | MP0002752_abnormal_somatic_nervous | 1.15465190 |
| 77 | MP0008875_abnormal_xenobiotic_pharmacok | 1.14238839 |
| 78 | MP0010329_abnormal_lipoprotein_level | 1.13794699 |
| 79 | MP0004133_heterotaxia | 1.13625443 |
| 80 | MP0009697_abnormal_copulation | 1.13202084 |
| 81 | MP0001666_abnormal_nutrient_absorption | 1.12220151 |
| 82 | MP0002295_abnormal_pulmonary_circulatio | 1.09826953 |
| 83 | MP0001958_emphysema | 1.09426297 |
| 84 | MP0004742_abnormal_vestibular_system | 1.08307623 |
| 85 | MP0002876_abnormal_thyroid_physiology | 1.06644058 |
| 86 | MP0003279_aneurysm | 1.06527776 |
| 87 | MP0009250_abnormal_appendicular_skeleto | 1.05223666 |
| 88 | MP0004134_abnormal_chest_morphology | 1.03644754 |
| 89 | MP0001270_distended_abdomen | 1.03469232 |
| 90 | MP0005275_abnormal_skin_tensile | 1.02095495 |
| 91 | MP0002229_neurodegeneration | 0.97755368 |
| 92 | MP0002066_abnormal_motor_capabilities/c | 0.97447382 |
| 93 | MP0001502_abnormal_circadian_rhythm | 0.96897760 |
| 94 | MP0001485_abnormal_pinna_reflex | 0.95246144 |
| 95 | MP0000013_abnormal_adipose_tissue | 0.89557515 |
| 96 | MP0002234_abnormal_pharynx_morphology | 0.87544186 |
| 97 | MP0001348_abnormal_lacrimal_gland | 0.86911920 |
| 98 | MP0002938_white_spotting | 0.86891269 |
| 99 | MP0004142_abnormal_muscle_tone | 0.86819797 |
| 100 | MP0002282_abnormal_trachea_morphology | 0.85163951 |
| 101 | MP0003937_abnormal_limbs/digits/tail_de | 0.84687459 |
| 102 | MP0008569_lethality_at_weaning | 0.84400985 |
| 103 | MP0001299_abnormal_eye_distance/ | 0.84102427 |
| 104 | MP0003879_abnormal_hair_cell | 0.83985776 |
| 105 | MP0001963_abnormal_hearing_physiology | 0.83081644 |
| 106 | MP0000049_abnormal_middle_ear | 0.82710282 |
| 107 | MP0000569_abnormal_digit_pigmentation | 0.80539308 |
| 108 | MP0005195_abnormal_posterior_eye | 0.80392519 |
| 109 | MP0002233_abnormal_nose_morphology | 0.79976903 |
| 110 | MP0005595_abnormal_vascular_smooth | 0.79487245 |
| 111 | MP0003633_abnormal_nervous_system | 0.79133062 |
| 112 | MP0005535_abnormal_body_temperature | 0.79096389 |
| 113 | MP0003634_abnormal_glial_cell | 0.77916911 |
| 114 | MP0000631_abnormal_neuroendocrine_gland | 0.77733680 |
| 115 | MP0003890_abnormal_embryonic-extraembry | 0.77095018 |
| 116 | MP0004085_abnormal_heartbeat | 0.75946336 |
| 117 | MP0002693_abnormal_pancreas_physiology | 0.75894911 |
| 118 | MP0002152_abnormal_brain_morphology | 0.73141593 |
| 119 | MP0009780_abnormal_chondrocyte_physiolo | 0.71552134 |
| 120 | MP0002069_abnormal_eating/drinking_beha | 0.69791177 |
| 121 | MP0005171_absent_coat_pigmentation | 0.68945802 |
| 122 | MP0008872_abnormal_physiological_respon | 0.68792852 |
| 123 | MP0003329_amyloid_beta_deposits | 0.66585298 |
| 124 | MP0004145_abnormal_muscle_electrophysio | 0.64259464 |
| 125 | MP0000751_myopathy | 0.63946800 |
| 126 | MP0006072_abnormal_retinal_apoptosis | 0.63619566 |
| 127 | MP0003631_nervous_system_phenotype | 0.62331269 |
| 128 | MP0001664_abnormal_digestion | 0.59651360 |
| 129 | MP0001944_abnormal_pancreas_morphology | 0.59472183 |
| 130 | MP0005389_reproductive_system_phenotype | 0.58453953 |
| 131 | MP0000026_abnormal_inner_ear | 0.56203896 |
| 132 | MP0008874_decreased_physiological_sensi | 0.54718290 |
| 133 | MP0003121_genomic_imprinting | 0.54329189 |
| 134 | MP0005551_abnormal_eye_electrophysiolog | 0.53420408 |
| 135 | MP0001542_abnormal_bone_strength | 0.53052947 |
| 136 | MP0003953_abnormal_hormone_level | 0.52826899 |
| 137 | MP0003283_abnormal_digestive_organ | 0.52476166 |
| 138 | MP0000534_abnormal_ureter_morphology | 0.49815646 |
| 139 | MP0001943_abnormal_respiration | 0.49720415 |
| 140 | MP0000015_abnormal_ear_pigmentation | 0.48305009 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Hypothermia (HP:0002045) | 5.32212281 |
| 2 | Myokymia (HP:0002411) | 5.20591534 |
| 3 | Ulnar claw (HP:0001178) | 4.81380703 |
| 4 | Limb dystonia (HP:0002451) | 4.65331703 |
| 5 | Pheochromocytoma (HP:0002666) | 4.47541442 |
| 6 | Neuroendocrine neoplasm (HP:0100634) | 4.08628557 |
| 7 | Action tremor (HP:0002345) | 3.83051912 |
| 8 | Focal motor seizures (HP:0011153) | 3.75945354 |
| 9 | Insidious onset (HP:0003587) | 3.70525094 |
| 10 | Termporal pattern (HP:0011008) | 3.70525094 |
| 11 | Premature rupture of membranes (HP:0001788) | 3.61111386 |
| 12 | Protrusio acetabuli (HP:0003179) | 3.54298647 |
| 13 | Abnormal autonomic nervous system physiology (HP:0012332) | 3.40735639 |
| 14 | Deep venous thrombosis (HP:0002625) | 3.39200107 |
| 15 | Peritonitis (HP:0002586) | 3.35465282 |
| 16 | Dysautonomia (HP:0002459) | 3.28209203 |
| 17 | Failure to thrive in infancy (HP:0001531) | 3.26297265 |
| 18 | Aortic dissection (HP:0002647) | 3.25972379 |
| 19 | Visual hallucinations (HP:0002367) | 3.22789452 |
| 20 | Gait imbalance (HP:0002141) | 3.22140239 |
| 21 | Ankle clonus (HP:0011448) | 3.21253527 |
| 22 | Hyperventilation (HP:0002883) | 3.19896929 |
| 23 | Keratoconus (HP:0000563) | 3.18048576 |
| 24 | Increased corneal curvature (HP:0100692) | 3.18048576 |
| 25 | Progressive cerebellar ataxia (HP:0002073) | 3.17914402 |
| 26 | Prolonged partial thromboplastin time (HP:0003645) | 3.12410715 |
| 27 | Genital tract atresia (HP:0001827) | 3.10349271 |
| 28 | Orthostatic hypotension (HP:0001278) | 3.10080143 |
| 29 | Agitation (HP:0000713) | 3.09783956 |
| 30 | Retinal dysplasia (HP:0007973) | 3.04614186 |
| 31 | Soft skin (HP:0000977) | 3.03699329 |
| 32 | Medial flaring of the eyebrow (HP:0010747) | 3.01013018 |
| 33 | Drooling (HP:0002307) | 3.00373933 |
| 34 | Neonatal short-limb short stature (HP:0008921) | 3.00247073 |
| 35 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.97813935 |
| 36 | Aortic aneurysm (HP:0004942) | 2.96222135 |
| 37 | Congenital primary aphakia (HP:0007707) | 2.94932282 |
| 38 | Follicular hyperkeratosis (HP:0007502) | 2.89734025 |
| 39 | * Focal seizures (HP:0007359) | 2.84028697 |
| 40 | Thyroid carcinoma (HP:0002890) | 2.81649197 |
| 41 | Nephrogenic diabetes insipidus (HP:0009806) | 2.81611866 |
| 42 | Vaginal atresia (HP:0000148) | 2.80606619 |
| 43 | Abnormality of dentin (HP:0010299) | 2.79852761 |
| 44 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.76391890 |
| 45 | Abnormal hair whorl (HP:0010721) | 2.76133659 |
| 46 | Amblyopia (HP:0000646) | 2.74555976 |
| 47 | Vascular tortuosity (HP:0004948) | 2.73765422 |
| 48 | Polyphagia (HP:0002591) | 2.67424386 |
| 49 | Abnormal ciliary motility (HP:0012262) | 2.67074099 |
| 50 | Cardiovascular calcification (HP:0011915) | 2.66619935 |
| 51 | * Febrile seizures (HP:0002373) | 2.65135599 |
| 52 | Exotropia (HP:0000577) | 2.65059237 |
| 53 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.58885705 |
| 54 | Excessive salivation (HP:0003781) | 2.58516825 |
| 55 | Hypoventilation (HP:0002791) | 2.51803148 |
| 56 | * Abnormality of pain sensation (HP:0010832) | 2.50270957 |
| 57 | * Impaired pain sensation (HP:0007328) | 2.50270957 |
| 58 | Foot dorsiflexor weakness (HP:0009027) | 2.50218814 |
| 59 | Pancreatic fibrosis (HP:0100732) | 2.49792701 |
| 60 | Arterial tortuosity (HP:0005116) | 2.45830105 |
| 61 | Truncal ataxia (HP:0002078) | 2.44909019 |
| 62 | Supranuclear gaze palsy (HP:0000605) | 2.43947765 |
| 63 | Hypercortisolism (HP:0001578) | 2.43557470 |
| 64 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.43309309 |
| 65 | Hypoplasia of the brainstem (HP:0002365) | 2.43309309 |
| 66 | Abnormality of the corticospinal tract (HP:0002492) | 2.41639266 |
| 67 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 2.41552163 |
| 68 | Abnormality of the wing of the ilium (HP:0011867) | 2.39929665 |
| 69 | Broad-based gait (HP:0002136) | 2.37845348 |
| 70 | Submucous cleft hard palate (HP:0000176) | 2.37434832 |
| 71 | Molar tooth sign on MRI (HP:0002419) | 2.37227307 |
| 72 | Abnormality of midbrain morphology (HP:0002418) | 2.37227307 |
| 73 | Menstrual irregularities (HP:0000858) | 2.35994704 |
| 74 | Acute necrotizing encephalopathy (HP:0006965) | 2.35885404 |
| 75 | Pachygyria (HP:0001302) | 2.35771638 |
| 76 | Myotonia (HP:0002486) | 2.34270232 |
| 77 | Lissencephaly (HP:0001339) | 2.33624180 |
| 78 | Vascular calcification (HP:0004934) | 2.32616913 |
| 79 | Autoamputation (HP:0001218) | 2.31902663 |
| 80 | Specific learning disability (HP:0001328) | 2.30451072 |
| 81 | Progressive macrocephaly (HP:0004481) | 2.25984963 |
| 82 | Conjugated hyperbilirubinemia (HP:0002908) | 2.20569764 |
| 83 | Mask-like facies (HP:0000298) | 2.19639375 |
| 84 | Abnormality of the common coagulation pathway (HP:0010990) | 2.19591859 |
| 85 | Abnormality of the foot musculature (HP:0001436) | 2.19146522 |
| 86 | Steppage gait (HP:0003376) | 2.17562322 |
| 87 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.17100438 |
| 88 | Morphological abnormality of the middle ear (HP:0008609) | 2.16005692 |
| 89 | Bladder diverticulum (HP:0000015) | 2.15646582 |
| 90 | Poor coordination (HP:0002370) | 2.14797485 |
| 91 | Hypophosphatemic rickets (HP:0004912) | 2.14002098 |
| 92 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.13801036 |
| 93 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.13801036 |
| 94 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.13263134 |
| 95 | Protruding tongue (HP:0010808) | 2.13214516 |
| 96 | Infantile muscular hypotonia (HP:0008947) | 2.12807647 |
| 97 | Postural tremor (HP:0002174) | 2.12744665 |
| 98 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.12227165 |
| 99 | Hammertoe (HP:0001765) | 2.10614726 |
| 100 | Abnormality of the vocal cords (HP:0008777) | 2.09716523 |
| 101 | Epileptic encephalopathy (HP:0200134) | 2.09592493 |
| 102 | Aplasia/Hypoplasia of the lens (HP:0008063) | 2.08846155 |
| 103 | Abnormality of proline metabolism (HP:0010907) | 2.07513589 |
| 104 | Hydroxyprolinuria (HP:0003080) | 2.07513589 |
| 105 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.07137532 |
| 106 | Mitral stenosis (HP:0001718) | 2.07079864 |
| 107 | Thyroid-stimulating hormone excess (HP:0002925) | 2.06900236 |
| 108 | Delayed gross motor development (HP:0002194) | 2.06247369 |
| 109 | Bifid tongue (HP:0010297) | 2.06221859 |
| 110 | Inability to walk (HP:0002540) | 2.06085771 |
| 111 | Absent speech (HP:0001344) | 2.04450786 |
| 112 | Shawl scrotum (HP:0000049) | 2.03548836 |
| 113 | Disproportionate short-trunk short stature (HP:0003521) | 2.02760430 |
| 114 | Ankle contracture (HP:0006466) | 2.02399785 |
| 115 | Anxiety (HP:0000739) | 2.01116236 |
| 116 | Prolonged QT interval (HP:0001657) | 2.00685363 |
| 117 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.99693298 |
| 118 | Hypobetalipoproteinemia (HP:0003563) | 1.99367195 |
| 119 | Spastic gait (HP:0002064) | 1.94545484 |
| 120 | Bulbous nose (HP:0000414) | 1.94125348 |
| 121 | Hyperthyroidism (HP:0000836) | 1.93235038 |
| 122 | Spontaneous abortion (HP:0005268) | 1.93152749 |
| 123 | Flared iliac wings (HP:0002869) | 1.92995274 |
| 124 | Increased number of teeth (HP:0011069) | 1.92452070 |
| 125 | * Generalized tonic-clonic seizures (HP:0002069) | 1.92006062 |
| 126 | Arthropathy (HP:0003040) | 1.91617757 |
| 127 | Distal arthrogryposis (HP:0005684) | 1.90971291 |
| 128 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.89648994 |
| 129 | Syncope (HP:0001279) | 1.88158812 |
| 130 | Type II lissencephaly (HP:0007260) | 1.86145296 |
| 131 | Lower limb muscle weakness (HP:0007340) | 1.84427704 |
| 132 | Metaphyseal dysplasia (HP:0100255) | 1.83983841 |
| 133 | Broad ribs (HP:0000885) | 1.82663003 |
| 134 | Acute encephalopathy (HP:0006846) | 1.82387499 |
| 135 | Hypotension (HP:0002615) | 1.81668582 |
| 136 | Broad alveolar ridges (HP:0000187) | 1.81340931 |
| 137 | Thoracolumbar scoliosis (HP:0002944) | 1.81184586 |
| 138 | Postaxial hand polydactyly (HP:0001162) | 1.80091106 |
| 139 | Joint hemorrhage (HP:0005261) | 1.80087718 |
| 140 | Torticollis (HP:0000473) | 1.79558170 |
| 141 | Abnormality of macular pigmentation (HP:0008002) | 1.79036859 |
| 142 | Fair hair (HP:0002286) | 1.78513762 |
| 143 | Hyperparathyroidism (HP:0000843) | 1.78413237 |
| 144 | Wrist flexion contracture (HP:0001239) | 1.78306506 |
| 145 | Wide anterior fontanel (HP:0000260) | 1.78035223 |
| 146 | Adrenal overactivity (HP:0002717) | 1.77538912 |
| 147 | Facial shape deformation (HP:0011334) | 1.75117506 |
| 148 | Potter facies (HP:0002009) | 1.75117506 |
| 149 | Genetic anticipation (HP:0003743) | 1.74871159 |
| 150 | Neoplasm of the thyroid gland (HP:0100031) | 1.74782811 |
| 151 | Mitochondrial inheritance (HP:0001427) | 1.73987234 |
| 152 | Pancreatic cysts (HP:0001737) | 1.73961283 |
| 153 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.73435191 |
| 154 | Rhinitis (HP:0012384) | 1.72918447 |
| 155 | EEG with generalized epileptiform discharges (HP:0011198) | 1.71845383 |
| 156 | Cutaneous finger syndactyly (HP:0010554) | 1.71811726 |
| 157 | True hermaphroditism (HP:0010459) | 1.71710944 |
| 158 | Urinary urgency (HP:0000012) | 1.71109398 |
| 159 | Prominent supraorbital ridges (HP:0000336) | 1.70781924 |
| 160 | Nephronophthisis (HP:0000090) | 1.69958638 |
| 161 | Short tibia (HP:0005736) | 1.68557174 |
| 162 | Ovoid vertebral bodies (HP:0003300) | 1.68503499 |
| 163 | Knee flexion contracture (HP:0006380) | 1.68377099 |
| 164 | Abnormal eating behavior (HP:0100738) | 1.67785392 |
| 165 | Midline defect of the nose (HP:0004122) | 1.67358511 |
| 166 | Striae distensae (HP:0001065) | 1.67101317 |
| 167 | Epileptiform EEG discharges (HP:0011182) | 1.66657243 |
| 168 | Hypsarrhythmia (HP:0002521) | 1.66198633 |
| 169 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.65753506 |
| 170 | Abnormal delivery (HP:0001787) | 1.65368902 |
| 171 | Abnormality of carpal bone ossification (HP:0006257) | 1.62191144 |
| 172 | Spastic tetraplegia (HP:0002510) | 1.61948566 |
| 173 | * Abnormality of salivation (HP:0100755) | 1.60623918 |
| 174 | Long toe (HP:0010511) | 1.58922481 |
| 175 | Supernumerary spleens (HP:0009799) | 1.58647977 |
| 176 | Aortic regurgitation (HP:0001659) | 1.58602669 |
| 177 | Short foot (HP:0001773) | 1.57174917 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 3.81878671 |
| 2 | NTRK1 | 3.69749923 |
| 3 | MINK1 | 2.80881004 |
| 4 | CASK | 2.59563538 |
| 5 | ERBB3 | 2.57948153 |
| 6 | MYLK | 2.57575713 |
| 7 | GRK5 | 2.50042162 |
| 8 | MAP4K2 | 2.39972064 |
| 9 | MAPK13 | 2.38759852 |
| 10 | ARAF | 2.27960200 |
| 11 | MAP2K7 | 2.25900049 |
| 12 | MARK1 | 2.25218452 |
| 13 | MAP3K4 | 2.14130849 |
| 14 | MAP3K12 | 2.13663421 |
| 15 | PINK1 | 2.11290088 |
| 16 | LIMK1 | 1.99235065 |
| 17 | MAP3K9 | 1.97256431 |
| 18 | LMTK2 | 1.92547819 |
| 19 | AKT3 | 1.90556418 |
| 20 | MAPKAPK3 | 1.89332160 |
| 21 | MAP3K2 | 1.86125501 |
| 22 | MAPK15 | 1.77317168 |
| 23 | DAPK2 | 1.70734120 |
| 24 | CAMKK2 | 1.60650614 |
| 25 | BMPR2 | 1.57978102 |
| 26 | LATS1 | 1.56964850 |
| 27 | SIK3 | 1.56000952 |
| 28 | RPS6KA2 | 1.55707011 |
| 29 | GRK7 | 1.52602052 |
| 30 | PHKG2 | 1.52094807 |
| 31 | PHKG1 | 1.52094807 |
| 32 | PIK3CG | 1.49030727 |
| 33 | GRK1 | 1.48144531 |
| 34 | NTRK2 | 1.47563027 |
| 35 | MAP2K4 | 1.46560914 |
| 36 | UHMK1 | 1.42770926 |
| 37 | PNCK | 1.42677599 |
| 38 | KSR2 | 1.38804663 |
| 39 | MATK | 1.38505793 |
| 40 | SGK223 | 1.35385417 |
| 41 | SGK494 | 1.35385417 |
| 42 | INSRR | 1.29179584 |
| 43 | DDR2 | 1.28875185 |
| 44 | MAPKAPK5 | 1.26039469 |
| 45 | SGK2 | 1.24131851 |
| 46 | CSNK1G3 | 1.19751830 |
| 47 | CSNK1G2 | 1.16790171 |
| 48 | RET | 1.12187267 |
| 49 | BRAF | 1.11296332 |
| 50 | ADRBK1 | 1.08164763 |
| 51 | PLK2 | 1.07109822 |
| 52 | MAP2K1 | 1.05170999 |
| 53 | PAK2 | 1.03248733 |
| 54 | PAK3 | 1.01542080 |
| 55 | FRK | 1.01485551 |
| 56 | PDGFRA | 0.96131660 |
| 57 | DYRK3 | 0.95830924 |
| 58 | WNK4 | 0.95542218 |
| 59 | FLT3 | 0.94956742 |
| 60 | TRIM28 | 0.94163187 |
| 61 | PRKCG | 0.93430803 |
| 62 | HIPK2 | 0.92150198 |
| 63 | LATS2 | 0.92043470 |
| 64 | BMPR1B | 0.91905180 |
| 65 | CAMK2D | 0.91518595 |
| 66 | CDK5 | 0.90388334 |
| 67 | STK24 | 0.89785873 |
| 68 | PRKCE | 0.88850416 |
| 69 | DYRK1B | 0.88666228 |
| 70 | CDK8 | 0.88623598 |
| 71 | TAOK3 | 0.85818654 |
| 72 | FER | 0.81541138 |
| 73 | CSNK1A1L | 0.79464306 |
| 74 | CAMK2B | 0.79327691 |
| 75 | ADRBK2 | 0.79166323 |
| 76 | MAP3K6 | 0.78507185 |
| 77 | WNK1 | 0.78217921 |
| 78 | STK39 | 0.77927817 |
| 79 | DYRK2 | 0.77741777 |
| 80 | CAMK2A | 0.76901916 |
| 81 | PRKG1 | 0.75278312 |
| 82 | PAK6 | 0.74864399 |
| 83 | WNK3 | 0.73849228 |
| 84 | CAMK2G | 0.73400628 |
| 85 | SIK2 | 0.73141436 |
| 86 | CSNK1G1 | 0.70425013 |
| 87 | TNIK | 0.67760625 |
| 88 | PRPF4B | 0.67539014 |
| 89 | SGK3 | 0.65571315 |
| 90 | TRPM7 | 0.64633846 |
| 91 | MAP3K5 | 0.64604201 |
| 92 | TNK2 | 0.64368940 |
| 93 | DAPK1 | 0.64233520 |
| 94 | PLK4 | 0.63512503 |
| 95 | PTK2 | 0.62686432 |
| 96 | EPHA3 | 0.62143991 |
| 97 | PKN1 | 0.61435138 |
| 98 | CDC42BPA | 0.60309758 |
| 99 | BCR | 0.55614043 |
| 100 | EPHB2 | 0.55058332 |
| 101 | MAP3K1 | 0.53602447 |
| 102 | SCYL2 | 0.51977293 |
| 103 | CLK1 | 0.51770618 |
| 104 | ROCK1 | 0.51736309 |
| 105 | CDK14 | 0.50079866 |
| 106 | STK38 | 0.50037102 |
| 107 | IRAK1 | 0.49973613 |
| 108 | IRAK2 | 0.49961112 |
| 109 | ABL2 | 0.49332597 |
| 110 | CAMKK1 | 0.48975578 |
| 111 | PRKAA1 | 0.48907980 |
| 112 | PRKCH | 0.48777763 |
| 113 | RPS6KB1 | 0.48159951 |
| 114 | PRKACA | 0.47505172 |
| 115 | PIK3CA | 0.46959376 |
| 116 | AURKA | 0.44970212 |
| 117 | NUAK1 | 0.44899257 |
| 118 | CDK19 | 0.44397058 |
| 119 | TGFBR2 | 0.43445076 |
| 120 | GSK3A | 0.43213569 |
| 121 | PIM2 | 0.43140155 |
| 122 | TIE1 | 0.43002888 |
| 123 | ZAK | 0.42626499 |
| 124 | ERBB2 | 0.42606595 |
| 125 | MAP2K2 | 0.42574131 |
| 126 | NME1 | 0.40057596 |
| 127 | PRKG2 | 0.39927996 |
| 128 | CSNK1D | 0.39109078 |
| 129 | PRKACG | 0.37441150 |
| 130 | CAMK1G | 0.37245087 |
| 131 | ERBB4 | 0.36220485 |
| 132 | PRKCZ | 0.36045056 |
| 133 | PRKCB | 0.34997107 |
| 134 | PRKACB | 0.34467055 |
| 135 | FGFR3 | 0.33893280 |
| 136 | YES1 | 0.33765655 |
| 137 | STK16 | 0.33715583 |
| 138 | CDK18 | 0.33343599 |
| 139 | DYRK1A | 0.33225754 |
| 140 | CSNK1E | 0.32806192 |
| 141 | STK38L | 0.32086503 |
| 142 | PRKD3 | 0.29220039 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Olfactory transduction_Homo sapiens_hsa04740 | 4.57302221 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.36537452 |
| 3 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 3.18652887 |
| 4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.87851559 |
| 5 | Insulin secretion_Homo sapiens_hsa04911 | 2.46762706 |
| 6 | * Taste transduction_Homo sapiens_hsa04742 | 2.27867172 |
| 7 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.25367200 |
| 8 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.23953468 |
| 9 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.23001941 |
| 10 | Serotonergic synapse_Homo sapiens_hsa04726 | 2.18096776 |
| 11 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.14084912 |
| 12 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.09637313 |
| 13 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.05764638 |
| 14 | Nicotine addiction_Homo sapiens_hsa05033 | 2.04573314 |
| 15 | Parkinsons disease_Homo sapiens_hsa05012 | 2.03041492 |
| 16 | Cholinergic synapse_Homo sapiens_hsa04725 | 2.02392560 |
| 17 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.94398920 |
| 18 | Circadian entrainment_Homo sapiens_hsa04713 | 1.90070937 |
| 19 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.89978723 |
| 20 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.85181869 |
| 21 | GABAergic synapse_Homo sapiens_hsa04727 | 1.84422302 |
| 22 | Morphine addiction_Homo sapiens_hsa05032 | 1.84364705 |
| 23 | Phototransduction_Homo sapiens_hsa04744 | 1.83697676 |
| 24 | Alzheimers disease_Homo sapiens_hsa05010 | 1.66064894 |
| 25 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.65702121 |
| 26 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.63174847 |
| 27 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.62189131 |
| 28 | Cocaine addiction_Homo sapiens_hsa05030 | 1.60542765 |
| 29 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.60454721 |
| 30 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.57425484 |
| 31 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.47575730 |
| 32 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.46163444 |
| 33 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.43369801 |
| 34 | Long-term potentiation_Homo sapiens_hsa04720 | 1.40033514 |
| 35 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.37517358 |
| 36 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.37355031 |
| 37 | Salivary secretion_Homo sapiens_hsa04970 | 1.32289594 |
| 38 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.31299337 |
| 39 | Huntingtons disease_Homo sapiens_hsa05016 | 1.29919142 |
| 40 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.29196376 |
| 41 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.28709314 |
| 42 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.25873768 |
| 43 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.19916015 |
| 44 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.19860511 |
| 45 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.19625344 |
| 46 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.19430634 |
| 47 | ABC transporters_Homo sapiens_hsa02010 | 1.19394094 |
| 48 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.18643456 |
| 49 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.16726424 |
| 50 | Retinol metabolism_Homo sapiens_hsa00830 | 1.16620355 |
| 51 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.15396754 |
| 52 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.14231218 |
| 53 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.09534469 |
| 54 | Renin secretion_Homo sapiens_hsa04924 | 1.08696298 |
| 55 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.08048250 |
| 56 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.06952872 |
| 57 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.05961176 |
| 58 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.05172569 |
| 59 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.03784148 |
| 60 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.03573618 |
| 61 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.03054739 |
| 62 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.01684013 |
| 63 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.00312937 |
| 64 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.99492003 |
| 65 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.99373287 |
| 66 | Long-term depression_Homo sapiens_hsa04730 | 0.97729738 |
| 67 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.97574330 |
| 68 | Gap junction_Homo sapiens_hsa04540 | 0.96970484 |
| 69 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.95602121 |
| 70 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.94292886 |
| 71 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.93848213 |
| 72 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.93393272 |
| 73 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.92183513 |
| 74 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.92167284 |
| 75 | Alcoholism_Homo sapiens_hsa05034 | 0.91499411 |
| 76 | Protein export_Homo sapiens_hsa03060 | 0.91356793 |
| 77 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.91101831 |
| 78 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.89047934 |
| 79 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.88754204 |
| 80 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.88488267 |
| 81 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.86686864 |
| 82 | Focal adhesion_Homo sapiens_hsa04510 | 0.83756249 |
| 83 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.82510812 |
| 84 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.82033559 |
| 85 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.81659028 |
| 86 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.81453087 |
| 87 | Melanogenesis_Homo sapiens_hsa04916 | 0.81105890 |
| 88 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.79680473 |
| 89 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.79631261 |
| 90 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.78526923 |
| 91 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.78106593 |
| 92 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.77909083 |
| 93 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.77333910 |
| 94 | Peroxisome_Homo sapiens_hsa04146 | 0.77221308 |
| 95 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.76212916 |
| 96 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.76027045 |
| 97 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.75917226 |
| 98 | Phagosome_Homo sapiens_hsa04145 | 0.75428441 |
| 99 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.75304622 |
| 100 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.75241694 |
| 101 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.72641195 |
| 102 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.72596324 |
| 103 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.72119122 |
| 104 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.71887270 |
| 105 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.70987731 |
| 106 | Glioma_Homo sapiens_hsa05214 | 0.70699987 |
| 107 | Axon guidance_Homo sapiens_hsa04360 | 0.70226922 |
| 108 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.68813128 |
| 109 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.66882841 |
| 110 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.66547311 |
| 111 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.65966739 |
| 112 | Thyroid cancer_Homo sapiens_hsa05216 | 0.65931620 |
| 113 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.64551751 |
| 114 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.63984883 |
| 115 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.63947256 |
| 116 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.63344357 |
| 117 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.63030560 |
| 118 | Prion diseases_Homo sapiens_hsa05020 | 0.62278991 |
| 119 | Endometrial cancer_Homo sapiens_hsa05213 | 0.61568805 |
| 120 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.58778528 |
| 121 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.58084955 |
| 122 | Basal transcription factors_Homo sapiens_hsa03022 | 0.57285774 |
| 123 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.56774935 |
| 124 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.56088941 |
| 125 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.55546967 |
| 126 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.55096549 |
| 127 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.53196320 |
| 128 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.51906129 |
| 129 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.49369204 |
| 130 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.46130809 |
| 131 | Melanoma_Homo sapiens_hsa05218 | 0.45903988 |
| 132 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.44172188 |
| 133 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.43659856 |
| 134 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.42263751 |
| 135 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.41285288 |
| 136 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.38535893 |
| 137 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.37672671 |
| 138 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.37659011 |
| 139 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.36171602 |
| 140 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.35924698 |
| 141 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.35361154 |
| 142 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.34873700 |
| 143 | Proteasome_Homo sapiens_hsa03050 | 0.33174899 |
| 144 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.32307955 |
| 145 | Bile secretion_Homo sapiens_hsa04976 | 0.31575327 |
| 146 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.31002030 |
| 147 | Histidine metabolism_Homo sapiens_hsa00340 | 0.30533019 |
| 148 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.29665162 |
| 149 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.28767305 |
| 150 | Circadian rhythm_Homo sapiens_hsa04710 | 0.26524030 |

